Our 20-Year Institutional Experience with Surgical Approach for Breast Hamartomas

dc.authoridOzmen, Vahit/0000-0003-2973-8247
dc.authoridAYDIN, Tahacan/0000-0002-8125-4808
dc.authoridÖzkurt, Enver/0000-0003-2597-3119;
dc.authorwosidOzmen, Vahit/AAE-3904-2020
dc.authorwosidAYDIN, Tahacan/AAD-7809-2022
dc.authorwosidOnder, Semen Yesil/AAE-3284-2020
dc.authorwosidCabıoğlu, Neslihan/AAZ-1196-2020
dc.authorwosidÖzkurt, Enver/AAL-3131-2021
dc.authorwosidTukenmez, Mustafa/ABA-8245-2020
dc.contributor.authorTurkyilmaz, Zeliha
dc.contributor.authorAydin, Tahacan
dc.contributor.authorYilmaz, Ravza
dc.contributor.authorOnder, Semen
dc.contributor.authorOzkurt, Enver
dc.contributor.authorTukenmez, Mustafa
dc.contributor.authorMuslumanoglu, Mahmut
dc.date.accessioned2024-06-12T10:55:15Z
dc.date.available2024-06-12T10:55:15Z
dc.date.issued2019
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjective: Hamartomas are rare, slowly-growing breast tumours. Clinical, radiological and histopathological examination together increase the diagnostic accuracy. To evaluate the clinicopathologic features of hamartomas and outline our clinical approach to hamartomas in our 20-year experience at our Breast Clinic. Materials and Methods: Between 1995 and 2015, 24 cases were retrospectively analyzed with a diagnosis of breast hamartoma at our Breast Clinic followed by excisional biopsy. Data was obtained on patient demographics, clinical examination, radiological findings and histopathological subtypes. Results: Of 1338 benign breast tumours excised from January 1995 to January 2015, 24 (1.8%) were identified as breast hamartoma. Median age of patients was 42 (range, 13-70), whereas the median tumour size was 5 cm (1-10 cm). On preoperative imaging, hamartoma was most commonly misdiagnosed as fibroadenoma. Pathological examination of the 24 biopsy specimens revealed 3 cases with pseudoangiomatous stromal hyperplasia, and another hamartoma associated with a radial scar within the centre of the lesion. Of those, one patient was diagnosed with malignant phylloides tumour in the same breast. At a median follow-up 58.4 months, none of the patients recurred or developed malignancy. Conclusion: Hamartomas can often be missed by clinicians, due to its benign nature which is poorly understood. Despite their slow growth, hamartomas can reach large sizes and can cause breast asymmetry. Although it is rare, hamartoma can be seen along with malignancy, as it is formed from similar components of breast tissue. Therefore, careful diagnosis and appropriate management including surgery are required.en_US
dc.identifier.doi10.5152/ejbh.2019.4624
dc.identifier.endpage175en_US
dc.identifier.issn2587-0831
dc.identifier.issue3en_US
dc.identifier.pmid31312793en_US
dc.identifier.scopus2-s2.0-85086594610en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage171en_US
dc.identifier.trdizinid368865en_US
dc.identifier.urihttps://doi.org/10.5152/ejbh.2019.4624
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/368865
dc.identifier.urihttps://hdl.handle.net/20.500.14551/19359
dc.identifier.volume15en_US
dc.identifier.wosWOS:000473357300007en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAvesen_US
dc.relation.ispartofEuropean Journal Of Breast Healthen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBreast Diseaseen_US
dc.subjectHamartomaen_US
dc.subjectPhyllodes Tumoren_US
dc.subjectMammary Hamartomaen_US
dc.subjectDuctal Carcinomaen_US
dc.subjectGiant Hamartomaen_US
dc.titleOur 20-Year Institutional Experience with Surgical Approach for Breast Hamartomasen_US
dc.typeArticleen_US

Dosyalar